Joshua Barer
Chief Executive Officer bij Hibiscus Capital Management
Vermogen: 422 899 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Joshua Barer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Rutgers State University of New Jersey
144
| College/University | Other Consumer Services | 144 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.
45
| Private Company | Investment Managers | 45 |
Trout Capital LLC
 Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco.
16
| Extinct | Investment Banks/Brokers | 16 |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Maxim Group LLC
 Maxim Group LLC Investment Banks/BrokersFinance Founded in 2002, Maxim Group LLC is a registered broker/dealer located in New York City. The firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products and global institutional equity, fixed-income and derivative sales and trading to a diverse range of corporate clients, institutional investors and high net-worth individuals. Maxim Group's niche is emerging-growth companies in a variety of sectors including healthcare, technology, retail and others. They utilize a fundamental, bottom-up approach to investment recommendations. The firm combines rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. The firm focuses on under-covered, small- to-mid-cap companies where valuation levels may be out of sync with fundamental trends. Maxim's coverage universe often represents attractive niche industries where stocks tend to be inefficient. This research coverage fills a void created by the downsized research ranks and shrinking coverage of small- to mid-cap stocks by large investment banks. Maxim Group is a member of FINRA, the MSRB, the SIPC, the ISE, NASDAQ and NYSE Arca.
9
| Subsidiary | Investment Banks/Brokers | 9 |
Trickle Up Program, Inc.
 Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Trickle Up Program, Inc. is an organization that aims to end extreme poverty by partnering with women. The non-profit company is based in New York, NY. The company believes that women are agents of change and key to breaking the intergenerational cycle of poverty. The organization invests in women and provides them with training and mentoring to build sustainable livelihoods and transform their futures. Trickle Up has reached many lives since 1979 and supports savings groups. The company works through partners and provide coaching in displaced contexts.
6
| Non-Profit Organization | Miscellaneous Commercial Services | 6 |
Hibiscus BioVentures LLC
3
| Private Company | 3 | |
Hibiscus Capital Management
 Hibiscus Capital Management Investment ManagersFinance Hibiscus Capital Management (Hibiscus Capital) is a venture capital subsidiary of Hibiscus BioVentures LLC. The firm is headquartered in Delaware.
2
| Private Company | Investment Managers | 2 |
Barer & Son Capital LLC
 Barer & Son Capital LLC Investment ManagersFinance Barer & Son Capital LLC (Barer & Son Capital) is a venture capital firm founded in 2017 by Sol Barer. The firm is headquartered in Mendham, New Jersey.
1
| Private Company | Investment Managers | 1 |
Family Promise, Inc.
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Joshua Barer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Private Equity Investor | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member Consultant / Advisor | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Advantasure, Inc.
 Advantasure, Inc. Miscellaneous Commercial ServicesCommercial Services Advantasure, Inc. provides management services for the healthcare industry. Its offers traditional administrative services such as bookkeeping, human resources management, and non-professional staffing; medical information systems; data mining and control; and physician risk management. The company was founded by Eric D. Moskow in 2011 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chairman | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Founder | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Corporate Officer/Principal | |
Moody's Investors Service, Inc.
 Moody's Investors Service, Inc. Insurance Brokers/ServicesFinance Moody's Investors Service, Inc. is a credit rating and investment research firm headquartered in New York City. They are a subsidiary of Moody's Corp. (NYSE: MCO). The firm performs international financial research and analysis on commercial and government entities and provides a variety of analytic tools for assessing credit risk. Their clients include creditors, investment banks and commercial banks. | Insurance Brokers/Services | Analyst-Equity Analyst-Fixed Income Analyst-Fixed Income Analyst-Equity | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Tufts University | College/University | Undergraduate Degree Director/Board Member Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Baylor College of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Semorex, Inc. | Director/Board Member Director/Board Member | ||
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Generic | Director/Board Member Chairman Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Vidac Pharma Ltd.
 Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Israël | 9 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Consumer Services | 20 |
| Health Technology | 19 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 358 |
| Corporate Officer/Principal | 175 |
| Independent Dir/Board Member | 109 |
| Undergraduate Degree | 87 |
| Chairman | 70 |
Sterkste connecties
| Insiders | |
|---|---|
| Jeffrey Kindler | 48 |
| Jerome Zeldis | 38 |
| Sol Barer | 32 |
| David Sidransky | 32 |
| Robert Spiegel | 30 |
| Eddy Shalev | 27 |
| Steven Altschuler | 27 |
| Jeffrey Berkowitz | 26 |
| David Shulkin | 25 |
| Sapna R. Srivastava | 21 |
| Harlan Weisman | 20 |
| Kevin M. Slawin | 20 |
| M. Hardwick | 18 |
| Terence Cryan | 18 |
| C Thomas | 17 |
- Beurs
- Insiders
- Joshua Barer
- Bedrijfsconnecties
